Overview
Type: Vanderbilt Initiative Award (ViA)
There is rapidly expanding knowledge associated with the health effects related to changes to the metabolome. Examples of this powerful diagnostic tool have been used for early detection of newborn diseases, diabetes and cancer to name just a few. This initiative will develop a novel Nuclear Magnetic Resonance (NMR) based in vitro diagnostic research (IVDr) platform at Vanderbilt. Through this investment in IVDr, Vanderbilt clinicians and researchers will gain access to this leading-edge technology and its powerful diagnostic features.
Lead Faculty in bold
COLLEGE OF ARTS AND SCIENCE
- Markus Voehler, Research Associate Professor of Chemistry
- John McLean, Professor of Chemistry
SCHOOL OF MEDICINE (BASIC SCIENCES)
- Kevin Schey, Professor of Biochemistry
- David Wasserman, Professor of Molecular Physiology and Biophysics
SCHOOL OF MEDICINE (CLINICAL)
- James Luther, Associate Professor of Medicine
- Kevin Niswender, Associate Professor of Medicine
- Danxia Yu, Assistant Professor of Medicine
STAFF
- Donald Stec, Director, Small Molecule NMR Facility